Companies

Monte Rosa Therapeutics, Inc. (GLUE) SEC filings

CIK 0001826457 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Net income (USD)-72.7 M-135.4 M-108.5 M-74.0 M

Latest filings

FiledFormDescriptionPeriod
2026-10-06442026-10-05
2026-10-018-K8-K items 7.01,8.01,9.012026-10-01
2026-09-088-K8-K items 7.01,8.01,9.012026-09-08
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-07-17442026-07-16
2026-07-16442026-07-15
2026-07-16144144
2026-07-15144144
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-07442026-07-06
2026-07-06442026-07-01
2026-07-06SCHEDULE 13D/ASCHEDULE 13D/A
2026-07-01442026-06-30
2026-06-30144144
2026-06-30442026-06-29
2026-06-30442026-06-29
2026-06-29144144
2026-06-29144144
2026-06-25442026-06-23
2026-06-25442026-06-23
2026-06-25442026-06-23
2026-06-24144144

Forms on file (last 1,000): 4 135, 8-K 52, 3 36, 144 32, SCHEDULE 13G/A 16, 10-Q 16, SC 13G/A 16, CORRESP 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=GLUE (0.002 USD), /gw/filings/filings?ticker=GLUE&form=8-K, /gw/filings/facts?ticker=GLUE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange